[{"address1": "22121-17th Avenue SE", "address2": "Suite 112", "city": "Bothell", "state": "WA", "zip": "98021", "country": "United States", "phone": "425-402-8400", "fax": "425-806-2999", "website": "https://www.helixbiomedix.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Ms. Robin L. Carmichael", "age": 66, "title": "President, CEO & Director", "yearBorn": 1957, "fiscalYear": 2011, "totalPay": 304350, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Kelly  Forsythe", "title": "Associate Director of Marketing", "fiscalYear": 2011, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1325289600, "maxAge": 86400, "priceHint": 2, "previousClose": 18.1, "open": 18.1, "dayLow": 18.1, "dayHigh": 18.1, "regularMarketPreviousClose": 18.1, "regularMarketOpen": 18.1, "regularMarketDayLow": 18.1, "regularMarketDayHigh": 18.1, "beta": 0.325, "volume": 163, "regularMarketVolume": 163, "averageVolume": 6, "bid": 18.25, "ask": 19.0, "marketCap": 4067215, "fiftyTwoWeekLow": 18.1, "fiftyTwoWeekHigh": 23.5, "priceToSalesTrailing12Months": 1.9687233, "fiftyDayAverage": 21.8708, "twoHundredDayAverage": 22.9216, "currency": "USD", "enterpriseValue": 2783251, "profitMargins": -1.25062, "sharesOutstanding": 224708, "bookValue": 6.939, "priceToBook": 2.608445, "lastFiscalYearEnd": 1325289600, "nextFiscalYearEnd": 1356912000, "mostRecentQuarter": 1348963200, "netIncomeToCommon": -2583671, "trailingEps": -11.75, "lastSplitFactor": "1:300", "lastSplitDate": 1357171200, "enterpriseToRevenue": 1.347, "enterpriseToEbitda": -1.195, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "HXBM", "underlyingSymbol": "HXBM", "shortName": "Helix BioMedix, Inc.", "longName": "Helix BioMedix, Inc.", "firstTradeDateEpochUtc": 922372200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e29c0d63-518a-3007-94b5-24c2392e8e39", "gmtOffSetMilliseconds": -14400000, "currentPrice": 18.1, "recommendationKey": "none", "totalCash": 216534, "totalCashPerShare": 1.307, "ebitda": -2328767, "quickRatio": 1.182, "currentRatio": 2.329, "totalRevenue": 2065915, "revenuePerShare": 12.465, "returnOnAssets": -0.58999, "returnOnEquity": -1.22531, "freeCashflow": -1083466, "operatingCashflow": -1818997, "revenueGrowth": 0.188, "grossMargins": 0.68961996, "ebitdaMargins": -1.12723, "operatingMargins": -1.59501, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]